The Pharmaceutical Journal·3 min read·medium
MHRA report finds insufficient data on bladder anticholinergics dementia risk
✦AI Summary
The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has concluded that current evidence is insufficient to confirm a direct link between bladder anticholinergic medicines and dementia. However, they advise healthcare professionals to prescribe the lowest effective dose for the shortest duration as a precautionary measure.
Wavebreak Media Premium/ Alamy Stock Photo
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in